Form 13-F position report

APPLIED MOLECULAR TRANS INC

Reported by Founders Fund VI Management LLC

AMTI CUSIP 03824M109 Manager CIK 0001853382

Reported 826,607 shares, unchanged from the prior quarter.

Reported value -61.3%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value 33.97% This manager · Q2 2022
Shares 826,607 Quarter-end amount reported
Reported value $2,405,000 Fair value at quarter end
Consecutive quarters held 3 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 11555000
2022-03-31 6216000
2022-06-30 2405000
2022-09-30 801000
2022-12-31 347175
2023-03-31 264514
2023-06-30 213265
2023-09-30 129777
2023-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

9 quarters
Quarterly reported position history for APPLIED MOLECULAR TRANS INC held by Founders Fund VI Management LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2023 Reduced 0 -826,607 (-100.0%) 0 $0 2024-02-14
Q3 2023 Unchanged 826,607 0 (0.0%) 0.98% $129,777 2023-11-14
Q2 2023 Unchanged 826,607 0 (0.0%) 1.84% $213,265 2023-08-14
Q1 2023 Unchanged 826,607 0 (0.0%) 3.1% $264,514 2023-05-15
Q4 2022 Added 826,607 +500,000 (153.1%) 3.74% $347,175 2023-02-14
Q3 2022 Reduced 326,607 -500,000 (-60.5%) 18.18% $801,000 2022-11-14
Q2 2022 Unchanged 826,607 0 (0.0%) 33.97% $2,405,000 2022-08-15
Q1 2022 Unchanged 826,607 0 (0.0%) 10.49% $6,216,000 2022-05-16
Q4 2021 New 826,607 +826,607 (0.0%) 18.03% $11,555,000 2022-02-14

Who else reported the position

82 managers reported APPLIED MOLECULAR TRANS INC for Q2 2022.

Managers reporting APPLIED MOLECULAR TRANS INC in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
EPIQ Capital Group LLC Reduced 9,063,746 -35,034 10.35% $26,376,000 9 qtrs
Capital World Investors Reduced 4,188,362 -35,602 < 0.01% $12,188,000 9 qtrs
Founders Fund V Management LLC Unchanged 3,611,615 0 84.9% $10,509,000 7 qtrs
MORGAN STANLEY Added 1,052,015 +39,933 < 0.01% $3,061,000 8 qtrs
Avoro Capital Advisors LLC Unchanged 1,030,000 0 0.06% $2,997,000 2 qtrs
BlackRock Inc Reduced 961,276 -1,092,296 < 0.01% $2,797,000 9 qtrs
VANGUARD GROUP INC Added 955,574 +24,471 < 0.01% $2,781,000 9 qtrs
Founders Fund VI Management LLC This report Unchanged 826,607 0 33.97% $2,405,000 3 qtrs
RENAISSANCE TECHNOLOGIES LLC Added 532,188 +103,988 < 0.01% $1,549,000 4 qtrs
Laurion Capital Management LP New 481,600 +481,600 0.02% $1,401,000 1 qtr
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 15, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
826,607
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.